Free Republic

A world-renowned oncologist has confirmed that ivermectin can be used to cure cancer after the top doctor used the wonder drug to treat over 1,000 terminally ill patients. The announcement was made by Dr. William Makis, a leading Canadian physician with expertise in radiology, oncology, and immunology.Makis spoke out in a new interview amid a flood of reports from around the world from doctors who are seeing unprecedented results from using a combination of ivermectin and fenbendazole to combat cancer. The subject recently attracted widespread attention when Hollywood star Mel Gibson dropped a bombshell about the treatment on Joe Rogan’s...

Scientists have discovered a remarkable way to destroy cancer cells. Stimulating aminocyanine molecules with near-infrared light caused them to vibrate in sync, enough to break apart the membranes of cancer cells. Aminocyanine molecules are already used in bioimaging as synthetic dyes.... "They are more than one million times faster in their mechanical motion than the former Feringa-type motors... "This is the first time a molecular plasmon is utilized in this way to excite the whole molecule and to actually produce mechanical action used to achieve a particular goal – in this case, tearing apart cancer cells' membrane.....This is also the...

A doctor is speaking up about the surge in cancer cases among young people - revealing 'every new patient' that comes to his clinic is under 45 years old. North Carolina's Duke University oncologist Dr Nicholas DeVito says he and his colleagues have experienced a complete demographic switch in recent years. Based on what he's seeing everyday, talking to patients on the ground and analyzing the data, he blames the rise of junk food diets. Nearly 75 percent of food consumed in the US is considered ultra-processed and it is teeming with additives and potentially harmful ingredients. Numerous studies have...

Japan’s top cancer doctor recently made headlines for openly admitting what many American doctors have been too afraid to say out loud: the COVID-19 mRNA vaccines are “the work of evil” and have amounted to what is “essentially murder.”

There follows a letter from Dr. Angus Dalgleish, Professor of Oncology at St George’s University of London, to Dr. Kamran Abbasi, the Editor in Chief of the BMJ. It was written in support of a colleague’s plea to Dr. Abbasi that the BMJ make valid informed consent for Covid vaccination a priority topic. Dear Kamran Abbasi, Covid no longer needs a vaccine programme given the average age of death of Covid in the U.K. is 82 and from all other causes is 81 and falling. The link with clots, myocarditis, heart attacks and strokes is now well accepted, as is...

@DrAseemMalhotra BREAKING: The UK’s most decorated oncologist/immunologist tells cancer specialists at RAD51 conference that the covid mRNA vaccine safe and effective mantra is ‘a BIG LIE’ Prof Angus Dalgleish presents data exposing that boosters are accelerating cancer. ‘Unbelievable’ Mary Talley Bowden MD:- Deaths running 26% above pre-pandemic levels.

There follows a letter from Dr. Angus Dalgleish, Professor of Oncology at St George’s University of London, to Dr. Kamran Abbasi, the Editor in Chief of the BMJ. It was written in support of a colleague’s plea to Dr. Abbasi that the BMJ make valid informed consent for Covid vaccination a priority topic. ************************************************************************ Dear Kamran Abbasi, Covid no longer needs a vaccine programme given the average age of death of Covid in the U.K. is 82 and from all other causes is 81 and falling. The link with clots, myocarditis, heart attacks and strokes is now well accepted, as...

Scientists at the Institute for Cancer Research in London said the DIY spit test would catch more aggressive tumours and lead to fewer false alarms than the current NHS system...Men simply spit into a tube at home and send the sample off for lab analysis...Their DNA is checked for high risk genes or damage that could indicate prostate cancer...The study, presented at the American Society of Clinical Oncology conference, trialled the test on 6,142 men at GP surgeries in the UK.

Cutting-edge cancer treatments are essentially useless for patients barely clinging to life, a new study shows. Chemotherapies, immunotherapies, targeted therapies and hormone therapies do not improve survival rates in patients with very advanced tumors near the end of life, according to findings published Thursday in the journal JAMA Oncology. "Since we don't see an improved survival benefit, oncologists should revisit their goals of care conversations with patients, and this information in the study should be explained to patients," said lead researcher Maureen Canavan, an associate research scientist with Yale Cancer Center. For the study, researchers analyzed records on more than...

New research suggests that patients who have insufficient levels of vitamin D before starting paclitaxel treatment are more likely to experience peripheral neuropathy. According to an analysis of 1,191 patients with early-stage breast cancer—using data collected in the SWOG S0221 study—20.7% of patients with vitamin D deficiency experienced at least a grade 3 level of chemotherapy-induced peripheral neuropathy (CIPN), compared to 14.2% of those with sufficient vitamin D levels. The researchers also found that inducing vitamin D deficiency in an accompanying mice model study caused neurotoxicity-like symptoms. "These results suggest that vitamin D supplementation in patients with lower levels of...

THOSE of us who knew from the beginning that the sequence of CoV-SARS-2 contained inserts which could not have possibly occurred naturally, and were similar to ones that had already been published from the Wuhan laboratory, have had to endure unbelievable scorn, scientific ostracism and the ignominy of being ‘cancelled’ by the MSM as well as by professional colleagues for nearly three years now. In the summer of 2020 a paper I co-authored, describing the findings of an Anglo-Norwegian team of scientists who had demonstrated unique ‘fingerprints’ of laboratory manipulation in the Covid virus, was suppressed in both the US...

Oncologist: “I’ve Never Seen Cancers Behaving Like This” So strange they’ve given it a brand new name: “Turbo Cancer”. How terrible is that? The name is exactly what it sounds like — cancers so extreme and so aggressive that you’re often dead within months. Unlike anything doctors have seen before in their careers. Now gee, I wonder what could have caused that? Did we embark on any massive exploratory new drug or inoculation recently with no prior safety testing? Anything like that come to mind? Crimes Against Humanity. Just watch this if you can stomach it: VIDEO AT LINK............... It’s...

Investigators have found that dasatinib, a drug commonly used to treat chronic myeloid leukemia, is strongly associated with kidney injury. The study team strongly believes this study will impact clinical practice significantly, changing standard of care and possibly introducing new black box warnings for dasatinib. Furthermore, the researchers point out that the incidence of kidney injury is a previously unknown severe side effect for this drug. This side effect, they report, is advertised to be rare; however, they observed it in 10% of all participants taking dasatinib. Of concern, they say, is that patients taking dasatinib are currently not screened...

Back in the 1920s, researchers discovered that cancer patients had sweet-smelling urine. First, the doctors were puzzled, but they soon realized that it was a result of elevated blood sugar levels. "In cancer patients, the cells do not respond well to the hormone insulin. It therefore takes more insulin to create the same effect in cancer patients. If you suffer from insulin resistance, your body has to produce more insulin than usual to be able to regulate the blood sugar," says Lykke Sylow. The body's ability to respond to insulin is impaired in both cancer patients and people with type...

The FDA-approved lung cancer drug osimertinib (sold under the brand name Tagrisso) slashes the risk of death by 51% for certain patients whose cancer is caught early, according to new trial data. “This should be the new standard of care for these patients,” Nathan Pennell, co-director of the Cleveland Clinic Lung Cancer Program, who wasn’t involved in the drug’s development, said in a statement for the American Society of Clinical Oncology. The drug: Lung cancer is the second-most common cancer in the world, with 2.2 million new diagnoses every year. The vast majority fall into a category called “non-small cell...

A little-noticed provision of the omnibus spending bill could give the agency power to ban off-label use of approved therapies.. Secreted within the 2023 omnibus appropriations bill—4,155 pages, spending $1.7 trillion—is a 19-line section that could change the way medicine is practiced. Physicians routinely prescribe drugs and employ medical devices that are approved and labeled by the Food and Drug Administration for a particular use. Yet sometimes physicians discern other beneficial uses for these technologies, which they prescribe for their patients without specific official sanction. The new legislation amends the Food, Drug and Cosmetic Act, or FDCA, to give the...

Continued treatment for patients with cancer near end-of-life escalates costs and may adversely affect the quality of care patients receive. Accordingly, over the last decade, major professional societies have recommended that clinicians decrease the use of systemic anti-cancer therapies at the end-of-life stage. Researchers revealed that despite these recommendations, aggressive cancer care at the end-of-life persists and there has been a substantial transition from the use of chemotherapy to immunotherapy. "Systemic anti-cancer therapy has changed dramatically following the approvals of multiple new targeted therapies," said Kerin Adelson, MD. Researchers used the nationwide Flatiron Health electronic health record (EHR)-derived database to...

Study finds certain immune cells sometimes ‘switch sides’ and actually help tumors grow; finding has implications for improving immunotherapyWhen working correctly, your immune system detects and responds to pathogens ranging from viruses to parasitic worms, as well as cancer cells and foreign objects such as wood splinters. Researchers at Tel Aviv University recently discovered that the cells in certain cancer patients can act as “double agents,” helping cancerous tumors grow rather than eradicate them. The study, published in the Cell Reports, found that immune cells called neutrophils play a critical role in interacting with cancerous growth. Neutrophils are continuously recruited...

A team of researchers working at the Indiana University School of Medicine, has developed a compound that can degrade the cancer-promoting protein SUMO1. In their paper published in the journal Science Translational Medicine, the group describes their work in attempting to find a degrader for what has been described as an undruggable cancer-related protein. Prior research has shown that there are some proteins that change cancer proteins in ways that help it form and spread, but which are considered to be undruggable, meaning that it appears unlikely that a drug could be developed that would prevent it from doing its...

Ingredients found in hair dye and anti-ageing cream could delay breast cancer progression by two years, scientists believe. Early research suggests they boost the effectiveness of radiotherapy when injected into a tumour before treatment. The cocktail of hydrogen peroxide, which bleaches hair, and hyaluronic acid, which moisturises skin, costs less than £100....